GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Accumulated Depreciation

Biomics Biopharma (ASX:BBM) Accumulated Depreciation : A$0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.


Biomics Biopharma Accumulated Depreciation Historical Data

The historical data trend for Biomics Biopharma's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Accumulated Depreciation Chart

Biomics Biopharma Annual Data
Trend
Accumulated Depreciation

Biomics Biopharma Semi-Annual Data
Accumulated Depreciation

Biomics Biopharma Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Biomics Biopharma Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines